Helisten H, Höckerstedt A, Wähälä K, Tiitinen A, Adlercreutz H, Jauhiainen M, Tikkanen M J
Department of Medicine, University of Helsinki, 00014 Helsinki, Finland.
J Clin Endocrinol Metab. 2001 Mar;86(3):1294-300. doi: 10.1210/jcem.86.3.7292.
Estrogens are known to be powerful antioxidants in lipid-aqueous systems, as demonstrated by their inhibition of low-density lipoprotein (LDL) oxidation in vitro. Studies reporting that endogenous human estrogens could be rendered fat-soluble by esterification with fatty acids in vivo, and the subsequent detection of such esters in blood and fat tissue suggested a possible mechanism explaining how estrogens might protect LDL. Because of their lipophilicity, esterified estrogens may become incorporated in the lipoprotein structure, providing antioxidant potential for the particles. We incubated labeled 17beta-estradiol with ovarian follicular fluid and with plasma in the absence and presence of the LCAT inhibitor DTNB. This was followed by ultracentrifugal isolation of LDL and high-density lipoprotein and analysis of the radioactive label in the "ester" and "free" fractions purified from these lipoproteins. The results indicated that LCAT-mediated synthesis of esterified 17beta-estradiol occurred in high-density lipoprotein particles, and suggested a novel cholesterol ester transfer protein-mediated mechanism for their transfer to LDL particles.
众所周知,雌激素在脂质 - 水体系中是强大的抗氧化剂,体外实验中其对低密度脂蛋白(LDL)氧化的抑制作用就证明了这一点。有研究报告称,内源性人类雌激素在体内可通过与脂肪酸酯化而变得具有脂溶性,随后在血液和脂肪组织中检测到此类酯,这提示了一种可能的机制来解释雌激素如何保护LDL。由于其亲脂性,酯化雌激素可能会掺入脂蛋白结构中,为这些颗粒提供抗氧化潜力。我们在有无卵磷脂胆固醇酰基转移酶(LCAT)抑制剂二硫代硝基苯甲酸(DTNB)的情况下,将标记的17β - 雌二醇与卵泡液和血浆一起孵育。随后通过超速离心分离LDL和高密度脂蛋白,并分析从这些脂蛋白中纯化出的“酯”和“游离”部分中的放射性标记。结果表明,LCAT介导的酯化17β - 雌二醇的合成发生在高密度脂蛋白颗粒中,并提示了一种由胆固醇酯转移蛋白介导的将其转移至LDL颗粒的新机制。